NeurologyOnline.net

Neurology Xagena

Search results for "Apomorphine"

Levodopa is standard, and often initial, therapy for patients with Parkinson's disease; however, with continued treatment and as the disease progresses, up to 80% of patients experience wearing-off sy ...


Levodopa / Carbidopa intestinal infusion represents one of the therapeutic options for advanced Parkinson’s disease patients with motor fluctuations and diskynesias unresponsive to other treatments. I ...


Apomorphine, a short-acting dopamine D1 and D2 receptor agonist, was the first dopamine receptor agonist used to treat Parkinson's disease. Subcutaneous Apomorphine is currently used for the managemen ...


Extensive published evidence supports the use of subcutaneously-administered Apomorphine as an effective therapy for Parkinson's disease ( PD ) but to date no consensus recommendations have been avail ...